Biotech

J & J Ebola Vaccine booster shots showed strong immune responses

Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...

 September 14, 2021 | News

Thermo Fisher Scientific to Further Expand Global Network of Single-Use Technology Manufacturing Sites

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashvil...

 September 10, 2021 | News

HaemaLogiX raises $10 million to advance multiple myeloma treatments

HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor w...

 September 09, 2021 | News

RMG-KB BIOACCESS FUND LAUNCHES with Worldwide Focus on Innovative Life Sciences Ventures

This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life scienc...

 September 08, 2021 | News

China to provide a best-in-class CAR-T therapy

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...

 September 07, 2021 | News

GenScript ProBio to Manufacture Innovative Antibody Drug

FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...

 September 06, 2021 | News

Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster

-Moderna, Inc.  a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has submitted for a conditional ...

 September 06, 2021 | News

Sartorius to join the DAX blue chip index

The life science group Sartorius will be admitted to the German DAX blue chip index. After the market closes on September 17, 2021, Sartorius preference sh...

 September 06, 2021 | News

Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based compani...

 September 02, 2021 | News

Agilent places a premium on the burgeoning digital pathology sector.

Agilent Technologies Inc. (NYSE: A) today announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-mar...

 September 02, 2021 | News

Single Cell Discoveries joins consortium to build a single-cell cancer atlas to find therapy resistant tumor cells

This collaborative research program aims to provide the cancer research community with a new gold standard workflow for single-cell sequencing by developin...

 September 02, 2021 | News

Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new ...

 August 30, 2021 | News

Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

 The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three yea...

 August 25, 2021 | News

AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics

Combining Carina’s advanced CAR-T platform technologies with AdAlta’s i-body targeting capability aims to create unique, next-generation bi-spe...

 August 25, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close